Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China

被引:4
|
作者
Zhou Li [1 ]
Cao Ya-li [2 ]
Li Wen-ge [2 ]
Fu Fang-ting [2 ]
Zhang Ling [2 ]
Wang Xiang [3 ]
Shi Xiao-hu [2 ]
机构
[1] China Japan Friendship Hosp, Dept Blood Purificat, Beijing 100029, Peoples R China
[2] China Japan Friendship Hosp, Dept Nephrol, Beijing 100029, Peoples R China
[3] China Japan Friendship Hosp, Dept Urol, Beijing 100029, Peoples R China
关键词
aristolochic acid nephropathy; end stage renal disease; hemodialysis; transitional cell carcinoma; urinary tract; CHRONIC DIALYSIS PATIENTS; TRANSPLANTATION; DISEASE; HERBS; RISK;
D O I
10.3760/cma.j.issn.0366-6999.2012.24.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011. Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%), breast cancer (6%), lung cancer (4%), thyroid cancer (2%), and hematologic cancer (2%). Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease. Death occurred in eight patients out of 49, and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120). Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China. Chin Med J 2012;125(24):4460-4465
引用
收藏
页码:4460 / 4465
页数:6
相关论文
共 49 条
  • [31] Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis
    Togashi, Yosuke
    Masago, Katsuhiro
    Fukudo, Masahide
    Terada, Tomohiro
    Ikemi, Yasuaki
    Kim, Young Hak
    Fujita, Shiro
    Irisa, Kaoru
    Sakamori, Yuichi
    Mio, Tadashi
    Inui, Ken-ichi
    Mishima, Michiaki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 601 - 605
  • [32] Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
    Zheng, Xi
    Wezel, Felix
    Azoitei, Anca
    Meessen, Sabine
    Wang, Wenya
    Najjar, Gregoire
    Wang, Xue
    Kraus, Johann M.
    Kestler, Hans A.
    John, Axel
    Zengerling, Friedemann
    Bolenz, Christian
    Guenes, Cagatay
    CANCERS, 2021, 13 (15)
  • [33] Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma Associated with End-stage Renal Disease
    Ikezawa, Eri
    Kondo, Tsunenori
    Hashimoto, Yasunobu
    Kobayashi, Hirohito
    Iizuka, Junpei
    Takagi, Toshio
    Omae, Kenji
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (11) : 1096 - 1100
  • [34] TOWARDS A RATIONAL STRATEGY FOR THE SURVEILLANCE OF PATIENTS WITH LYNCH SYNDROME (HEREDITARY NON-POLYPOSIS COLON CANCER) FOR UPPER TRACT TRANSITIONAL CELL CARCINOMA
    Acher, Peter
    Kiela, Geraldine
    Thomas, Kay
    O'Brien, Timothy
    BJU INTERNATIONAL, 2010, 106 (03) : 300 - 302
  • [35] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    CANCER, 2005, 103 (11) : 2298 - 2303
  • [36] A STUDY ON SERUM ADENOSINE-DEAMINASE AND URINARY ARYLSULFATASE-A ACTIVITIES IN SQUAMOUS AND TRANSITIONAL-CELL CARCINOMA OF BLADDER-CANCER PATIENTS
    ELTOUKHY, MA
    EBIED, SA
    ELSHAZLY, LY
    HUSSEIN, NG
    MAHDY, MM
    ABULAZM, T
    SAAD, AA
    MEDICAL SCIENCE RESEARCH, 1994, 22 (04): : 271 - 273
  • [37] Basal cell carcinoma: what new can be learned about the most common human cancer? A cross-sectional prospective study of 180 cases in a single centre
    Chlebicka, Iwona
    Stefaniak, Aleksandra
    Matusiak, Lukasz
    Szepietowski, Jacek C.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 1 - 6
  • [38] Urine Phthalate Metabolites are Elevated in Patients with Esophageal Squamous Cell Carcinoma and Associated with Advanced Cancer Stage and Poor Survival
    Chen, Yen-Hao
    Huang, Wan-Ting
    Lee, Wen-Chin
    Chen, Ching-Mei
    Cheng, Fu-Jen
    Kung, Chia-Te
    Wang, Chin-Chou
    Wang, Liang-Jen
    Ou, Yu-Che
    Li, Shau-Hsuan
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 989 - 1001
  • [39] Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary
    Davis, Michelle
    Rauh-Hain, J. Alejandro
    Andrade, Carolina
    Boruta, David M., II
    Schorge, John O.
    Horowitz, Neil S.
    May, Taymaa
    del Carmen, Marcela G.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 760 - 766
  • [40] Chronic Lymphocytic Leukemia Is Associated With Decreased Survival of Patients With Malignant Melanoma and Merkel Cell Carcinoma in a SEER Population-Based Study
    Brewer, Jerry D.
    Shanafelt, Tait D.
    Otley, Clark C.
    Roenigk, Randall K.
    Cerhan, James R.
    Kay, Neil E.
    Weaver, Amy L.
    Call, Timothy G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 843 - 849